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ABSTRACT: Objective: To analyze the expenditure of  the Ministry of  Health with osteoporosis treatment in 
the Brazilian Public Health System (SUS) in 2008–2010 triennium and estimate the influence of  demographic, 
regional and disease related variables on average expenditure per procedures performed. Methods: A cross-sectional, 
descriptive and analytical study based on secondary data from DATASUS related to procedures for the elderly 
with a diagnosis of  osteoporosis and related fractures. For the statistical analysis and multivariate model, Stata 
11.0 was used. Results: According to the findings, 3,252,756 procedures related to the osteoporosis treatment 
among the elderly were carried out in Brazil during the 2008 – 2010 period, totalizing R$ 288,986,335.15. 
The age group that most had procedures was 60 – 69 years (46.3%); the population of  80 years or older 
showed the highest spending per procedure, around R$ 106 million in three years. The women were majority 
in terms of  quantity (95.6%) and expense (76%) of  procedures. The average cost per procedure showed a large 
gap between men and women, nearly 7 times (R$ 480.14 versus R$ 70.85, respectively). The ambulatory care 
procedures predominated in quantity (96.4%) and the hospital procedures predominated in resources (70.4%). 
It was found that there is no single standard for groups of  procedures when these are analyzed separately. 
Conclusion: A disaggregated analysis of  expenditure by procedures groups extracted from the SUS Management 
System of  the Table of  Procedures, Medicines, Orthotics, Prosthetics and Special Materials allowed a detailed 
overview of  federal spending on the osteoporosis treatment in the elderly from Brazil. 
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INTRODUCTION
Osteoporosis is the most common osteometabolic disease among elderly, due to its high 
incidence and to the increased prevalence of  fractures by bone’s fragility1, representing, 
worldwide, one of  the greatest challenges for contemporary public health.
Nowadays, worldwide, osteoporosis affects approximately 7% of  men and 17% of  
women; from these, 70% are aged 80 years old or older2. In Europe, United States anf  Japan, 
osteoporosis affects approximately 75 million people and over 8 million hip fractures are 
estimated to happen in the next 50 years3. In Latin America, studies on the prevalence of  
hip fracture report a frequency of  2 cases every 10 thousand people4. 
In Brazil, it is estimated that osteoporosis affects 10 million people, with a prevalence 
of  11 to 23.8% for all kinds of  fracture by bone fragility4. Martini et al.5 report that, from 
the 54,364 individuals who were interviewed, aged ≥ 18 years old, 4.4% of  them reported 
having medical diagnosis for osteoporosis, with a higher prevalence among women (7 versus 
1.3% men). When stratified by age, the prevalence tends to increase: in the population 
aged ≥ 65 years old, the prevalence is 22% for both gender (32.7% for women and 5.1% 
for men). According to Marques Neto et al.6, only one out of  five people receive some 
kind of  treatment.
RESUMO: Objetivo: Analisar o dispêndio do Ministério da Saúde com o tratamento de osteoporose no Sistema 
Único de Saúde (SUS) no triênio 2008–2010 e estimar a influência de variáveis demográficas, regionais e associadas 
à doença nos gastos médios por procedimentos realizados. Métodos: Estudo transversal, descritivo e analítico com 
base em dados secundários do DATASUS relacionados a procedimentos para idosos com diagnóstico de osteoporose 
e de fraturas associadas. Para a análise estatística e para o modelo multivariado, foi utilizado o programa Stata 11.0. 
Resultados: Foram realizados 3.252.756 procedimentos relacionados ao tratamento de osteoporose em idosos do 
Brasil no triênio 2008 – 2010, que totalizaram R$ 288.986.335,15. A faixa etária de 60 – 69 anos (46,3%) foi a que 
mais realizou procedimentos, e a população de 80 ou mais anos foi a que apresentou maior gasto por procedimento, 
em torno de R$ 106 milhões no triênio. As mulheres foram majoritárias em termos de quantidade (95,6%) e de 
gastos (76%) com procedimentos. O gasto médio por procedimento apresentou uma grande disparidade entre 
homens e mulheres, de quase 7 vezes (R$ 480,14 versus R$ 70,85, respectivamente). Os procedimentos ambulatoriais 
predominaram em quantidade (96,4%) e os hospitalares, em recursos (70,4%). Verificou-se que não há um padrão 
único para os grupos de procedimentos, quando estes são analisados separadamente. Conclusão: A análise 
desagregada das despesas por grupos de procedimentos do Sistema de Gerenciamento da Tabela de Procedimentos, 
Medicamentos, Órtese, Prótese e Materiais Especiais do SUS permitiram uma visão mais detalhada dos gastos 
federais com o tratamento da osteoporose em idosos no Brasil.
Palavras-chave: Osteoporose. Idoso. Terapêutica. Honorários e preços. Sistema Único de Saúde. Gastos.
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As for the costs related to osteoporosis, there is a great disparity of  values among health 
systems, due to the method adopted and the kind of  costs included in the studies. Haussler 
et al.7 estimated the osteoporosis cost for Germany, finding a value of  € 5.4 billion, including 
costs with medical drugs, hospitalizations fractures and rehabilitation. Brown et al.8 
indicate spendings of  US$ 1.15 billion in New Zealand, considering costs referring to 
osteoporosis and osteoporotic fractures. Martin et al.9, in their retrospective study with 
765 Americans, estimated costs of  US$ 17.9 million for the treatment of  osteoporotic 
fractures; the prospective study of  Wiktotowicz et al.10, in Canada, with 504 individuals, 
estimated an investment of  US$ 659 million for the treatment of  hip fractures. In Brazil, 
some retrospective or cross-sectional studies present different samples and methods, 
limiting then the representativeness of the Brazilian population3. Bortolon et al.11, in the 
2006–2008 triennium, estimated costs of  around R$ 121.5 million for the treatment of  
femoral fractures of  1% of  the elderly hospitalized in the period. 
No populational based studies on the specific costs for osteoporosis in Brazil, which 
would take into account the handling recommended by the Ministry of  Health, were 
found. According to the Clinical and Therapy Guidelines Protocol (CTGP)12, the use of  
the densitrometric criteria by the World Health Organization for the clinical doagnosis 
is recommended, based on the T-score classification: normal (T-score ≥ -1), osteopenia 
(T-score < -1 and > -2.5) and osteoporosis (T-score ≤ -2.5)13. For the treatment, it is 
recommended the supplementation with calcium and vitamin D, estrogens, bisphosphonates 
(alendronate, risedronate and pamidronate), raloxifene and calcitonine12, all provided 
by the Brazilian Public Health System (SUS).  
It is necessary to know the distribution of  financial resources spent by the SUS with this 
disease, since there is a tendency to the increase of  the number of  elderly in Brazil, and the 
available treatments tend to be costly, both in terms of  diagnosis and treatment. This study 
aimed at analyzing the expenditure of  the Ministry of  Health with the treatment of  osteoporosis 
in SUS in the 2008–2010 triennium and estimating the associations in average expenses by 
procedures performed on demographic, regional and disease-related variables.
METHODS
A cross-sectional study was performed, with descriptive and analytical characteristics, 
based on secondary data from health information systems regarding the expenses by the 
Ministry of  Health on ambulatorial and hospital care in SUS for elderly with associated 
osteoporosis diagnosis and fractures in the 2008 – 2010 triennium.
The secondary production data and the expenses with ambulatorial and hospital procedures 
related to osteoporosis were analyzed, based on the data source of  the Outpatient Information 
System (SIA/SUS) and the Hospital Information System (SIH/SUS) under the Ministry 
of  Health’s perspective. In this sense, it was decided to have an indentation only of  the 
resources paid out by federal entities, and the remaining ones — states and municipalities — 
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were excluded from this investigation. Moreover, only direct expenses (medical drugs and 
consultations, tests, surgeries, protheses etc.) were included in this analysis, since the indirect 
ones (related to productivity loss, absenteeism and premature death) are not responsability of  
the Ministry of  Health. The same situation is true for the intangible costs (pain and suffering) 
which are diffused in the information system of  the DATASUS, making its measurement 
impossible (other diseases of  the International Classification Diseases – ICD-10 – not related 
to osteoporosis), given that the DATASUS was developed in order to fulfill an accounting 
role, focusing on procedures, rather than on patients.
The identification of  the procedures related to osteoporosis and to fractures was made 
through the ICD-10, being registered in the Table Management System of  Procedures, 
Medical drugs, Orthotics, Prosthetics and Special Materials of  SUS (SIGTAP), available, 
in the Health Information Systems of  the Ministry of  Health, in this case, the SIH/SUS 
and the SIA/SUS14-16. The ICD-10 selected were: 
1. M80 – osteoporosis with pathological fracture (M80.1-80.9); 
2. M81– osteoporosis without pathological fracture (M80.1-80.9); 
3. S22 – Fracture of  rib(s), sternum and thoracic spine and S22.0 – Fracture of  thoracic 
vertebra; 
4. S32 – Fracture of  lumbar spine and pelvis and S32.0 – Fracture of  lumbar vertebra; 
5. S52.5 – Fracture of  lower end of  radius; 
6. S72 – Fracture of  femur and S72.0 – Fracture of  neck of  femur.
The ICD-10 fractures were selected considering, from the epidemiological and clinical 
point of  view, the most important and the most related to osteoporosis ones17, as well as 
the ones considered as a risk factor for the determination of  the highest risk of  fracture by 
osteoporosis12.
In order to assure greater consistency to the expenses analysis, we used the SIGTAP groups 
which presented production, according to the ICD-10 selected, available in the SIH/SUS and 
in the SIA/SUS14-16. They were: 
1. medical drugs; 
2. procedures for diagnostic purposes - tests; 
3. clinical procedures; 
4. surgical procedures; 
5. orthotics, prosthetics and special materials (OPME); and 
6. additional health care actions.
Moreover, the populational denominator from the Brazilian Institute of  Geography and 
Statistics (IBGE) for the census years of  201018 was used. This resource was used in order to 
obtain the average expenditure measure of  the elderly population, since the information 
systematization of  the DATASUS is based on procedures rather than on users.  
This study was approved by the Research Ethics Committee of  the Faculdade de Ciências 
da Saúde of  the Universidade de Brasília (UnB).
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The descriptive statistic was used in order to analyze the characteristics of  the records 
on osteoporosis procedures in Brazilian elderly by absolute and relative frequencies, average 
values and standard deviation (SD) and the total amount of  expenses with osteoporosis. 
The multiple (adjusted) linear regression analysis was used in order to verify the association 
between the dependent variable (expenses with the treatment of  osteoporosis and fractures) 
and the demographic variables (gender and age range), the ICD-10 for osteoporosis and 
fracture and the geographic region, estimating the regression coefficients (β) and the confidence 
intervals of  95% (95%CI). All independent variables were part of  the adjusted analysis. 
For all the inferential analyses, the significance level considered was 5%. All the analyses were 
performed and stratified by the year of  the data (2008, 2009 and 2010) and by the group of  
procedure. The Stata 11.0 software was used for the statistical analyses.
RESULTS
In Tables 1 a 3, it is observed the distribution of  information in the years of  2008, 2009 
and 2010, according to the type of  osteoporosis and fractures, considering the ICD-10, the 
age range, the gender, geographic regions, the group of  the recommended procedure and 
the information system from which the data is derived. 
R$ 288,986,335.15 were spent with 3,252,756 procedures related to osteoporosis in elderly 
in Brazil in the 2008–2010 triennium. From this, R$ 89,343,911.73 were spent in 2008, with 
1,100,959 procedures; in 2009, R$ 102,395,316.43 were spent with 1,274,333 procedures and, 
in 2010, R$ 97,247,106.99 with 877,464 procedures. 
When analyzing the data from each year of  the triennium, it is observed that the age range 
which has performed the most procedures was 60 – 69 years of  age, with 47.2% on 2008, 
46% in 2009 and 45.5% in 2010, followed by the age range from 70 to 79 years of  age, with 
37.9% in 2008, 38.6% in 2009 and 38.1% in 2010, and 80 years of  age or more, with 14.8% in 
2008, 15.4% in 2009 and 16.4% in 2010. However, when analyzing the expenses, it is observed 
that the population of  80 years of  age was the one which presented the highest expenses 
over the period: R$ 31,515,377.65 in 2008, R$ 37,225,809.12 in 2009 and R$ 38,205,988.69 
in 2010, and the highest average values related to the procedures was R$ 193.15 in 2008, 
R$ 189.03 in 2009 and R$ 265.79 in 2010, which represents, on average, approximately 4 times 
the average expenditure of  the age range 60 – 69 years of  age.
As for the quantity of  procedures, women were the majority, with an average of  95.6% 
in the entire period. A similar pattern is observed on relation to the expenses, though in 
smaller proportion for each year of  the triennium: 77.8% in 2008, 76.7% in 2009 and 74.4% 
in 2010. When the average expenditure by procedure is verified, there is a great difference 
between men and women, since a difference of  almost 7 times was observed in each year 
analyzed — R$ 416.69 (men) versus R$ 65.96 (women) in 2008; R$ 420.40 (men) versus R$ 64.48 
(women) in 2009 and R$ 646.90 (men) versus R$ 86.23 (women) in 2010.
Table 1. General data of osteoporosis by groups of procedures from Unified Health System Management System of the Table of Procedures, Medicines, Orthotics, Prosthetics 
and Special Materials. Brazil, 2008. 
Year 2008
Variables













Qty. Cost Qty. Cost Qty. Cost  Qty. Cost  Qty. Cost Qty.. Cost Qty. Cost
Gender
Male 30,634 471,481.76 3,559 214,684.72  3,365 689,519.62 10,085 18,483,240.45 21 4,752.70 7 188.10 47,671 19,863,867.35 
Female 928,060 23,616,424.24 94,733 5,268,488.18 10,018 1,247,724.69 20,273 39,299,666.62 142 44,739.45 62 3,001.20 1,053,288 69,480,044.38 
Age range (years)
60 – 69 451,137 11,812,988.27 57,188 3,179,702.01 5,072 512,788.39 6,794 10,966,044.46 44 17,125.00 38 1,901.55 520,273 26,490,549.68 
70 – 79 370,935 9,034,297.49 31,721 1,779,203.20 4,339 618,540.14 10,443 19,891,507.42 54 13,148.40 30 1,287.75 417,522 31,337,984.40 
≥ 80 136,622 3,240,620.24 9,383 524,267.69 3,972 805,915.78 13,121 26,925,355.19 65 19,218.75 1 - 163,164 31,515,377.65 
Geographic region
North 26,645 683,752.90 7,120 396,633.28 835 136,832.29 919 1,487,814.85 28 6,825.90 19 1,291.05 35,566 2,713,150.27 
Northeast 374,978 8,231,276.95 31,022 1,739,232.92  3,475 380,429.57 5,763 10,242,143.45 54 16,324.85 30 1,405.80 415,322 20,610,813.54 
Midwest 87,235 1,747,261.13 8,091 450,940.85 819 98,796.68 1,731 2,939,314.39 33 6,210.00 2 - 97,911 5,242,523.05 
Southeast 406,619 11,802,662.77 46,309 2,573,892.13 6,837 1,016,136.70 16,407 32,301,600.03 37 17,562.20 15 477.60 476,224 47,712,331.43 








737,626  18,108,474.38 94,685 5,264,620.94 6,047 163,133.00 3 84.00 109 28,515.65 60 2,800.80 838,530 23,567,628.77 
Fractures - - 6 2,617.02 5,922 1,708,865.64 30,355 57,782,823.07 - - - - 36,283 59,494,305.73 
System
SIA 958,694 24,087,906.00 98,286 5,480,555.88   7,461 228.378.67 3 84.00 163 49,492.15 69  3,189.30 1,064,676 29,849,606.00 
SIH - - 6 2,617.02  5,922 1,708,865.64 30,355 57,782,823.07 - - - - 36,283 59,494,305.73 
Total 958,694 24,087,906.00 98,292 5,483,172.90 13,383 1,937,244.31 30,358 57,782,907.07 163 49,492.15 69 3,189.30 1,100,959 89,343,911.73
Qty.: quantity; SIA: Ambulatorial Information System; SIH: Hospital Information System.
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Table 2. General data of osteoporosis by groups of procedures from Unified Health System Management System of the Table of Procedures, Medicines, Orthotics, Prosthetics 
and Special Materials. Brazil, 2009. 
Ano 2009
Variables













Qty. Cost Qty. Cost Qty. Cost Qty. Cost  Qty. Cost Qty.. Cost Qty. Cost
Gender
Male 38,132 537,238.61  3,903 227,070.20 3,488 761,449.12 11,250 22,353,083.47 26  7,554.75 23 1,843.35 56,822 23,888,239.50 
Female 1,090,305 25,832,323.79 94,537 5,273,951.10 10,488 1,607,768.46 22,021 45,775,930.93 52 13,638.10 108 3,464.55 1,217,511 78,507,076.93 
Age range (years)
60 – 69 516,994 12,500,520.37 56,697 3,158,928.55 4,486 554,280.63 7,332 12,743,616.51 45 11,283.35 76 3,886.05 585,630 28,972,515.46 
70 – 79 443,319 10,096,270.09 32,100 1,803,541.20 4,864 811,488.20 11,414 23,478,522.81 20 5,747.70 55 1,421.85 491,772 36,196,991.85 
≥ 80 168,124 3,772,771.94   9,643 538,551.55 4,626 1,003,448.75 14,525 31,906,875.08 13  4,161.80 - -   196,931 37,225,809.12 
Geographic region
North 38,563 1,160,379.86  7,900 437,520.58 816 155,748.95 982 1,685,499.17 14 2,720.20 37 2,429.10 48,312 3,444,297.86 
Northeast 389,570 8,408,977.10 29,022 1,633,187.79 3,859 573,246.51 6,359 12,137,026.60 2 632.40 68 2,574.00 428,880 22,755,644.40 
Midwest 110,557 2,377,348.80  9,942 552,409.01 914 110,673.71 2,062 3,680,502.09 5 1,135.40 - -   123,480 6,722,069.01 
Southeast 494,515 12,407,564.37 45,427 2,510,850.45 6,771 1,193,523.56 17,850 37,780,051.74 39 11,314.65 22 255.30 564,624 53,903,560.07 








883,770  20,658,031.15  4,423 5,261,771.03 5,587 98,875.44 - - 33 8,975.70 103 3,179.10 983,916 26,030,832.42 
Fractures - - 6 3,383.51 6,844 2,162,151.26 33,271 68,129,014.40 - - - -   40,121 70,294,549.17 
System
SIA 1,128,437 26,369,562.40 98,434 5,497,637.79 7,132 207,066.32 - - 78 21,192.85 131 5,307.90 1,234,212 32,100,767.26 
SIH - - 6 3,383.51 6,844 2,162,151.26 33,271 68,129,014.40 - - -   -   40,121 70,294,549.17 
Total 1,128,437 26,369,562.40  98,440 5,501,021.30 13,976 2,369,217.58 33,271 68,129,014.40 78 21,192.85 131  5,307.90 1,274,333 102,395,316.43 
Qty.: quantity; SIA: Ambulatorial Information System; SIH: Hospital Information System.
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Table 3. General data of osteoporosis by groups of procedures from Unified Health System Management System of the Table of Procedures, Medicines, Orthotics, Prosthetics 
and Special Materials. Brazil, 2010. 
Year 2010
Variables













Qty. Cost Qty. Cost Qty. Cost  Qty. Cost Qty. Cost Qty. Cost Qty. Cost
Gender
Male 19,567 487,420.53 4,471 274,698.71 2,651 489,844.26 11,756 23,643,851.32 11 3,983.60 40 3,117.95 38,496 24,902,916.37 
Female 698,804 16,238,975.58 106,665 6,064,287.88 10,395 997,403.80 23,023 49,026,768.12 35 9,441.99 46 7,313.25 838,968 72,344,190.62 
Age range (years)
60 – 69 322,826  8,103,655.30 64,565 3,660,675.85 4,517 424,732.48 7,555 13,745,334.04 17 4,885.29 59 9,108.70 399,539 25,948,391.66 
70 – 79 281,814  6,121,131.34 35,664 2,060,399.85 4,841 510,753.63 11,819 24,393,497.52 20 6,038.00 24 906.30 334,182 33,092,726.64 
≥ 80 113,731  2,501,609.47 10,907 617,910.89 3,688 551,761.95 15,405 34,531,787.88 9 2,502.30 3 416.20 143,743 38,205,988.69 
Geographic region           
North 23,903 341,812.94 8,110 449,251.24 653 130,764.74 960 1,615,568.43 7 2,123.10 53 9,101.15 33,686 2,548,621.60 
Northeast 242,869 12,325,175.19 29,060 1,690,754.69 4,253 287,079.56 6,393 12,458,141.65 7 2,139.80 19 1,197.90 282,601 26,764,488.79 
Midwest 53,830 559,026.16 10,660 610,923.23 740 65,463.94 2,145 4,138,465.74 3 340.20 3 4.95 67,381 5,374,224.22 
Southeast 343,703  3,001,239.74 55,539 3,141,781.00 6,178 832,904.56 18,743 40,179,403.78 9 2,243.29 6 48.00 424,178 47,157,620.37 




128,035 1,327,693.02 4,043 240,167.59 2,084 120,574.94 - - 30 9,860.19 50 7,611.60 134,242 1,705,907.34 
M81 without 
fracture
590,336 15,398,703.09 107,088 6,093,344.75 6,358 136,999.60 1 22.27 16 3,565.40 36 2,819.60 703,835 21,635,454.71 
Fractures - - 5 5,474.25 4,604 1,229,673.52 34,778 72,670,597.17 0 - - - 39,387 73,905,744.94 
System
SIA 718,371 16,726,396.11 111,131 6,333,512.34 8,442 257,574.54 1 22.27 46 13,425.59 86 10,431.20 838,077 23,341,362.05 
SIH - - 5 5,474.25 4,604 1,229,673.52 34,778 72,670,597.17 0 - - - 39,387 73,905,744.94 
Total 718,371 16,726,396.11 111,136 6,338,986.59 13,046 1,487,248.06 34,779 72,670,619.44 46 13,425.59 86 10,431.20 877,464 97,247,106.99 
Qty.: quantity; SIA: Ambulatorial Information System; SIH: Hospital Information System.
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It is also observed the great participation of  ambulatorial procedures (96.4%) in relation 
to hospital ones (3.6%). In terms of  expenditure, this pattern is inverted, being the hospital 
procedures the ones in need of  more resources (66.6, 68.6 and 76% each year) in relation to 
the ambulatorial ones (33.4, 31.4 and 24%, respectively). 
The Southeast region has the largest share of  procedures (43.2% in 2008, 44.3% in 2009 and 
48.3% in 2010) and the highest expenses when compared to the remaining regions (53.4% in 
2008, 52.4% in 2009 and 48.5% in 2010). This is directly related to the great concentration of  
elderly population in this region (46%). Regions North and Northeast present a participation 
in average total expenditure of  approximately 3 and 24.3%, respectively, lower than its elderly 
population proportion (5 and 26%, respectively), and a divergent pattern in relation to the 
total procedures number in the triennium (3.6 and 34.6%, respectively). Regions Midwest 
and South showed proportionality in relation to the elderly population’s participation and 
to the expenses incurred with the treatment of  osteoporosis (6 and 15.2%, respectively), 
differing in relation to the number of  procedures (8.9 and 7.8%, respectively), as described 
in Tables 1 to 3.
Table 4 presents the adjusted analysis between the expenditures on osteoporosis and 
fractures treatment and the independent variables according to each year and group of  
procedure. In 2008, 2009 and 2010, for the procedures related to drugs, the populational 
subgroups which spent more with osteoporosis were the younger female elderly (except 2010), 
whose analyzed ICD-10 was the osteoporosis with pathological fracture one (except 2009) 
and the ones from regions Southeast (in 2008), North (in 2009) and Northeast (in 2010). 
For the procedures related to the tests, in 2008 and 2009, the elderly who spent more 
with osteoporosis were the male ones, whose analyzed ICD-10 was fracture. In the year 
of  2010, for the procedures related to the tests, no variable was associated to higher or 
lower expenses with osteoporosis. For the clinical procedures, the male elderly (in 2008), 
from the fractures ICD-10 (in 2008, 2009 and 2010) and from the North region (in 2010) 
were the ones who spent more on osteoporosis. As for the surgical procedures, the elderly 
subgroups which spent more with osteoporosis were those above 80 years of  age, females 
(2008 and 2010), with ICD-10 of  fractures (2008) and from regions Southeast (in 2008) and 
South (2009 and 2010). For the procedures of  OPM, the elderly in Southeast and South, 
in 2009, were the ones who spent more with osteoporosis. In the procedures related to 
complementary actions, female elderly (in 2010), living in Northeast (in 2010) and North 
(in 2008 and 2009), were the ones who spent more with osteoporosis. 
DISCUSSION
In Brazil, over the last few decades, the interest in using databases originated by health 
services as a tool for the development of  policies, the analysis of  the epidemiological systems 
in health, for planning and resource management has been expanding19,20. According to 
Bittencourt et al.21, the systems provided by DATASUS are an important source in this context, 
Continue...




























β (95%CI) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value
Age range (years)
60 – 69 Reference < 0.01 Reference 0.16 Reference 0.07 Reference < 0.01 Reference 0.52 Reference 0.66
70 – 79 -1.9 (-2.0 – -1.8) 0.3 (0.1 – 0.6) -10.4 (-23.2 – 2.3) 279.8 (242.8 – 316.8) -161.1 (-310.4 – -11.8)  -1.9 (-21.8 – 17.8)
≥ 80 -2.3 (-2.5 – -2.1) 0.1 (-0.4 – 0.5)  -8.0 (-21.9 – 5.7) 423.4 (387.4 – 459.3) -87.5 (-237.0 –  61.9) -49.2 (-121.1 – 22.6)
Gender
Male Reference < 0.01 Reference < 0.01 Reference < 0.01 Reference 0.02 Reference 0.23 Reference 0.54




Reference < 0.01 Reference < 0.01 Reference < 0.01 Reference 0.02 Reference 0.16 Reference 0.92
M81 without 
fracture
-0.8 (-0.9 – -0.6) -4.3 (-5.1 – -3.6) -21.5 (-39.8 – -3.2) - -32.7 (-194.1 – 128.6) -0.9 (-29.7 – 27.8)
Fractures – 373.6 (355.7 – 391.5) 241.9 (223.3 – 260.6) 1.620.9 (259.7 – 2982.1) - -
Geographic region
North Reference < 0.01 Reference 0.07 Reference 0.69 Reference < 0.01 Reference 0.76 Reference 0.02
Northeast -3.5 (-4.0 – -3.1) 0.4 (-0.1 – 1.0) 22.9 (-0.7 – 46.6) 113.4 (29.6 –  197.3) 68.0 (-99.1 – 235.1) -19.6 (-41.3 – 2.0)
Midwest -5.3 (-5.8 – -4.9) -0.1 (-0.7 – 0.6) -1.5 (-31.5 – 28.3) 70.8 (-25.3 –  167.0) -71.0 (-256.3 – 114.3) -65.9 (-120.2 – -11.6)
Southeast  3.4 (3.0 – 3.9) -0.1 (-0.6 – 0.4) 4.5 (-17.7 – 26.8) 310.5 (230.5 – 390.5) 204.0 (-9.4 – 417.6) -35.4 (-61.9 –  -8.9)
South  0.2 (-0.2 – 0.6) 0.2 (-0.5 – 0.9) 10.0 (-16.5 – 36.7) 297.7 (213.7 – 381.8) -32.7 (-194.1 – 128.6) -61.3 (-106.1 – -16.5)
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Adjusted analysis  
(multivariate)




β (95%CI) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value
Age range (years)
60 – 69 Reference < 0.01 Reference 0.48 Reference 0.08 Reference < 0.01 Reference 0.18 Reference 0.36
70 – 79 -1.3 (-1.4 – -1.2) 0.4 (-0.1 – 1.0) -0.2 (-24.6 – 24.6) 304.7 (260.3 – 349.0) 41.1 (-29.2 – 111.4) -1.5 (-17.6 – 14.4)
≥ 80 -1.4 (-1.6 – -1.3) 0.1 (-0.9 – 1.0) -7.1 (-33.0 – 18.8) 440.9 (398.1 – 483.8) 70.3 (-15.0 – 155.8) -  
Gender
Male Reference < 0.01 Reference < 0.01 Reference 0.27 Reference 0.12 Reference 0.7 Reference 0.07
Female 9.5 (9.2 – 9.9) -2.3 (-3.7 – -0.8) 13.2 (-10.6 – 37.1) 20.3 (-14.2 – 55.0) -13.6 (-83.9 – 56.6) -27.1 (-54.8 – 0.5)
ICD-10             
M80 with 
fracture
Reference < 0.01 Reference < 0.01 Reference < 0.01 Reference - Reference 0.84 Reference  0.39
M81 without 
fracture
1.1 (0.9 –  1.2) -3.0 (-4.4 – -1.5) -58.1 (-92.4 – -23.9) - 5.4 (-57.4 – 68.3) -15.1 (-43.1 – 12.8)
Fractures - 504.7(468.9 – 540.4) 254.2 (220.2 – 288.3) - - -  
Geographic region
North Reference < 0.01 Reference 0.4 Reference 0.51 Reference < 0.01 Reference 0.02 Reference 0.02
Northeast -8.5 (-8.8 – -8.2) 1.0 (-0.1 – 2.1) 36.8 (-8.9 – 82.7) 145.1 (44.2 – 246.0) 77.8 (-122.0 – 277.6) -2.1 (-22.8 – 18.4)
Midwest -8.3 (-8.7 – -8.0) 0.2 (-1.0 – 1.5) -3.3 (-60.4 – 53.7) 48.9 (-65.0 – 162.9) 26.0 (-108.0 – 160.0) -  
Southeast -4.6 (-4.9 – -4.3) -0.1 (-1.1 – 0.9) -4.7 (-48.4 – 39.0) 348.1 (251.6 – 444.5) 83.1 (-3.4 – 169.7) -27.8 (-49.2 – -6.4)
South -8.7 (-9.1 – -8.3) 4.3 (2.8 – 5.7) -13.8 (-64.7 – 36.9) 375.1 (273.8 – 476.4) 105.1(10.4 – 199.7) -26.6 (-62.8 – 9.5)
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 Adjusted analysis 
(multivariate)










β (95%CI) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value β (95%CI ) p-value
Age range (years)
60 – 69 Reference < 0.01 Reference 0.77 Reference 0.43 Reference < 0.01 Reference 0.37 Reference 0.15
70 – 79  -2.8 (-4.1 – -1.6) 0.9 (-1.5 – 3.4) -5.6 (-20.4 – 9.1) 231.0 (183.7 – 278.4) 59.8 (-14.7 – 134.3) -185.0 (-348.6 – -21.4)
≥ 80 -3.7 (-5.4 – -2.1) -0.1 (-4.0 – 3.7) -14.7 (-31.1 – 1.7) 401.9 (356.2 – 447.6) 15.2 (-80.1 – 110.6) -28.1 (-363.6 – 307.3)
Gender
Male Reference < 0.01 Reference 0.12 Reference   0.07 Reference < 0.01 Reference 0.16 Reference < 0.01




Reference < 0.01 Reference 0.71 Reference < 0.01 Reference 0.19 Reference 0.15 Reference 0.06
M81 without 
fracture
-5.0 (3.5 – 6.5) -2.5 (-8.6 – 3.4) -43.2 (-61.4 – -25.1) -2.110.0(99.3 – 1079.2) -59.0 (-141.1 – 22.9) -149.2(-300.1 – 1.6)
Fractures - 1.033.6(865.4 – 201.8) 217.6(197.5 – 237.7) - - -
Geographic region
North Reference < 0.01 Reference 0.71 Reference < 0.01 Reference < 0.01 Reference 0.7 Reference 0.01
Northeast 35.7 (32.4 – 38.9) 2.8 (-1.8 – 7.5) -83.1 (-113.2 – -53.1) 242.0 (131.5 – 352.4) 27.0 (-90.0 – 144.1)   299.8 (-491.3 – 108.3)
Midwest -4.6 (-8.3 – -0.9) 1.8 (-3.6 – 7.3) -117.0 (-155.2 – -78.7) 254.8 (130.9 – 378.6) -153.1 (-320.3 – 13.9) -456.7(-803.0 – 110.5)
Southeast -5.3 (-8.5 –  -2.1) 1.1 (-3.3 – 5.5) -110.0(-139.5 – -80.6) 435.8 (330.3 – 541.4) -12.0 (-128.9 – 104.8) -308.1(-581.6 – 34.6)
South -5.1 (-8.7 – -1.3) 2.1 (-3.8 – 8.0) -118.9 (-153.8 – -84.0) 477.8 (367.4 – 588.0) 28.1 (-67.3 – 123.5) -261.1 (-534.8 – 12.5)
Adjusted analysis by all the independent variables.
OPM: orthosis, prosthesis and special materials; β: regression coefficient; 95%CI: confidence interval of 95%.
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for they have nationwide coverage, free access, in addition to having internal consistency 
and coherence with evidences found in literature. 
The SIH/SUS is the only one with nationwide coverage, originated in the Hospitalization 
Authorizations (AIH) — destined for the payment of  hospitalizations in public hospitals 
and in private ones in partnership with SUS — and the advantage of  providing diagnostic, 
demographic and geographic information for each hospitalization21. The SIA/SUS, in turn, 
aims at registering the visits and procedures performed in each health establishment on 
ambulatorial basis, focusing on production and, consequently, in the actual payment for 
services provided by22. In this sense, some limitations concerning this base may arise, such 
as the absence of  procedures performed for exceeding the financial limit of  the operation 
and divergences due to fraudulent alterations of  codes23, in order to get a better payment. 
This way, the evidence risen by this study may be underestimated due to these features, and 
becoming a limitation in this study. However, these systems are still important sources of  
information for knowing national spenditure22. 
In this work, it was verified that women are more often in use of  osteoporosis related 
procedures, presenting higher expenses in an overall point of  view. However, when adjusting 
total expenditure by quantity, it is observed that men have a higher average cost per procedure. 
This is explained, partly, by the higher frequency of  men in more complex procedures24,25, 
which may indicate a possible delay in starting the treatment, searching for medical care in 
advanced stages of  the diseases. For instance, considering all six groups of  procedures, men 
used only 4.4% of  the total, but this relation changes when we observe the data by group of  
procedures. In the specific case of  surgical procedures, which are highly complex and costly, 
men are responsible for 33% of  the procedures performed in those 3 years. This is corroborated 
by Siqueira et al.26, when identifying higher occurrence of  osteoporotic fractures in men, with 
high incidence or mortality and morbidity and significant costs. In the same direction, Oliveira 
et al.27 identified a 50% higher risk of  fractures in men when comparing to women, considering 
a sample of  3,214 individuals in the city of  Pelotas (RS).
Moreover, since it is a silent and asymptomatic disease (until a fracture actually 
happens), prevention is essential. The primary osteoporosis diagnosis is clinical, later 
complemented by bone densitometry (gold standard) 12,13. In this sense, based on the data 
observed in this study, it was verified that men have a lower frequency of  going under 
bone densitometry (11,933 tests in the triennium, representing annual average of  3.8%) 
when compared to women (295,935 tests in the triennium, representing annual average 
of  96.2%). Thus, without the confirmation of  the diagnosis, the possible treatments are 
delayed (drug based ones or not), aggravating the patient’s health condition. 
As to age range, 80 years old or older patients had he lowest number of  procedures 
(14.8% in 2008, 15.4% in 2009 and 16.4% in 2010) in relation to the remaining ones, though 
with highest cost (35.3, 36.3 and 39.3%, respectively). These data are distributed annually 
in higher proportions among the groups of  surgical (64.7, 66.5 and 74.7%) and drug-based 
(27, 5.7 and 6.7%) procedures, characterizing the use of  such resources primarily to the 
treatment of  osteoporosis fractures. 
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Regarding the distribution of  expenses related to osteoporosis in Brazilian regions, there 
was a higher participation — both absolute and relative — of  the Southeast region when 
compared to the others, even adjusted by the number of  elderly residing there; the opposite 
occurs in Northeast in terms expenses related to the elderly population. This expenditure 
pattern may be associated to the climatic, racial and genetic factors27. This data is also 
corroborated by Silveira28, in studies carried out in the Southeast and Northeast regions, 
in which it was observed a possible influence of  the climatic conditions in order to justify 
the found data.
As for the years of  analysis, there was a sharp decrease in the number of  procedures in 
2010. This is explained by the change in agreements between the federate entities, where the 
liability for some drugs became states and municipalities’ matters, according to the ordinance 
2,981, of  November 26th, 2009. It is noteworthy, however, that, in terms of  expenses, this 
drop was smaller. For instance, the decrease in the number of  procedures was 45% between 
2009 and 2010; now regarding the expenses, it was 5% in the same period. 
In relation o the ICD-10, the osteoporosis without fracture is the majority in terms 
of  quantity and cost of  the drugs, representing 76.9, 78.3 e 82.1% and 75.2, 78.3 and 92, 
each year, respectively. Out of  the total procedures identified by ICD-10 on fractures, 
there were 115,791 registers in the triennium, summing up 3.6% of  the total. These are 
essentially hospital ones and they represented 3.3% in 2008, 3.1% in 2009 and 4.5% in 
2010. It is worth noting that, despite the reduced number of  procedures related to the 
remaining ICDs, the amount spent is substantial, representing 70% of  the triennium’s 
total and, each year, 66.6, 68.5 and 76%, respectively. The same is not true for ICDs of  
osteoporosis with fracture, which present reduced participation in the total cost of  this 
disease. One possible explanation lies in the fact that this ICD-10 is not commonly used 
in hospitals, since there are no records of  surgical procedure. The expenses 92.5% with 
medical drugs prevailed in the triennium, representing, each year, 95.2, 94.1 and 77.8%, and 
the expenses with tests were 5% in the triennium, featuring 3.4, 3.8 e 14.0%, respectively. 
This discrepancy is due to the kind of  test used in the ICDs, since the one with the highest 
financial impact for ICD-10 osteoporosis with and without fracture was the dual-energy 
bone densitometry of  spinal column (R$ 55.34). 
CONCLUSION
Based on the data found in this study, we obtained a general overview of  the 
expenses spent by the Ministry of  Health with the treatment of  osteoporosis in 2008, 
2009 and 2010. There was a progress towards disaggregating expenses by groups of  
SIGTAP procedures, allowing a more detailed view of  the expenses made. Moreover, 
multivariate models were used in order to estimate the magnitude (regression coefficient) 
and direction (coefficient signal) of  variables which may explain the expenses related 
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to osteoporosis in Brazil. It was found that there is no single pattern for the groups of  
procedures, when these are analyzed separately. 
In the group of  medical drugs, there was a higher expense in procedures by women 
aged 60 to 69 years old and whose ICD-10 would relate to osteoporosis with pathological 
fracture. In the group of  medical testing, more was spent on procedures with men under 
fracture treatment. In the group of  clinical procedures, there was a higher expense by 
procedure for men (except in 2009 and 2010) of  the North region (only in 2010), under 
treatment of  fractures. In the group of  surgical procedures, there was a higher expense 
by procedure with women (except in 2009) in the South and Southeast regions, who were 
80 years old or older. In the group of  OPM procedures, there was a higher expense with 
the elderly from the South region. In the group of  complementary actions procedures, 
women in North (in 2008 and 2009) and Northeast (in 2010) presented higher cost per 
performed procedure.  
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